| Q43125916 | Adherence to screening guidelines for hepatitis C among HIV-positive patients |
| Q41662784 | Antibody screening tests variably overestimate the prevalence of hepatitis C virus infection among HIV-infected adults in Ghana. |
| Q90332258 | Are we on the precipice of a new epidemic? Risk for hepatitis C among HIV-negative men-, trans women-, and trans men- who have sex with men in the United States |
| Q47559564 | Assessing Racial Disparities in HCV Infection and Care Outcomes in a Southern Urban Population. |
| Q40078485 | Attitudes and potential barriers towards hepatitis C treatment in patients with and without HIV coinfection |
| Q36590782 | Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levels |
| Q47553589 | Chronic hepatitis C virus infection and subsequent HIV viral load among women with HIV initiating antiretroviral therapy |
| Q42267774 | Coinfection with hepatitis C virus among HIV-positive people in the Kathmandu Valley, Nepal |
| Q36158135 | Darunavir and ritonavir total and unbound plasmatic concentrations in HIV-HCV-coinfected patients with hepatic cirrhosis compared to those in HIV-monoinfected patients |
| Q36167452 | Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain |
| Q35586252 | Drug use, hepatitis C, and service availability: perspectives of incarcerated rural women |
| Q91057942 | Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology |
| Q34451707 | Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with pre |
| Q37305516 | Favorable Socioeconomic Status and Recreational Polydrug Use Are Linked With Sexual Hepatitis C Virus Transmission Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men. |
| Q57817476 | Ficolin-1 and Ficolin-3 Plasma Levels Are Altered in HIV and HIV/HCV Coinfected Patients From Southern Brazil |
| Q35098577 | Findings from integrated behavioral and biologic survey among males who inject drugs (MWID) - Vietnam, 2009-2010: evidence of the need for an integrated response to HIV, hepatitis B virus, and hepatitis C virus |
| Q40350672 | Geographical variations of risk factors associated with HCV infection in drug users in southwestern China |
| Q36065064 | HIV and HCV Co-Culture Promotes Profibrogenic Gene Expression through an Epimorphin-Mediated ERK Signaling Pathway in Hepatic Stellate Cells |
| Q93217404 | HIV control programs reduce HIV incidence but not HCV incidence among people who inject drugs in HaiPhong, Vietnam |
| Q28541708 | HIV-, HCV-, and co-infections and associated risk factors among drug users in southwestern China: a township-level ecological study incorporating spatial regression |
| Q38391718 | Hepatitis C and HIV Coinfection for Social Workers in Public Health, Medical and Substance Use Treatment Settings |
| Q36083688 | Hepatitis C treatment initiation in HIV-HCV coinfected patients |
| Q37332212 | Hepatitis C virus serosorting in people who inject drugs: sorting out the details. |
| Q28540864 | Hepatitis C virus testing in adults living with HIV: a need for improved screening efforts |
| Q57211847 | High Mortality Among Non-HIV-Infected People Who Inject Drugs in Bangkok, Thailand, 2005-2012 |
| Q38881551 | High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada |
| Q47550704 | Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant. |
| Q33840260 | Hurdles to the Development of Effective HBV Immunotherapies and HCV Vaccines |
| Q38236179 | Latest pharmacotherapy options for treating hepatitis C in HIV-infected patients. |
| Q41400740 | Multiplexed testing for HIV and related bacterial and viral co-infections at the point-of-care: quo vadis? |
| Q30405829 | Neural dysregulation during a working memory task in human immunodeficiency virus-seropositive and hepatitis C coinfected individuals |
| Q36901498 | Plasma and intracellular ribavirin concentrations are not significantly altered by abacavir in hepatitis C virus-infected patients |
| Q33604112 | Prevalence and Associated Factors of Suicidal Ideation and Attempt among People Living with HIV/AIDS at Zewditu Memorial Hospital, Addis Ababa, Ethiopia: A Cross-Sectional Study |
| Q53449717 | Psychosocial health and suicidal ideation among people living with HIV/AIDS: A cross-sectional study in Nanjing, China. |
| Q92299256 | Risk Factors Associated with Linkage to Care among Suburban Hepatitis C-Positive Baby Boomers and Injection Drug Users |
| Q33589224 | Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV |
| Q36260469 | Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients |
| Q39893879 | Seroprevalence of HCV markers among HIV infected patients from Curitiba and metropolitan region |
| Q37322802 | Suicidal Ideation, Attempt, and Determining Factors among HIV/AIDS Patients, Ethiopia. |
| Q35115722 | The geographic distribution patterns of HIV-, HCV- and co-infections among drug users in a national methadone maintenance treatment program in Southwest China |
| Q37189852 | The iron homeostasis network and hepatitis C virus - a new challenge in the era of directly acting antivirals |
| Q64099588 | Trends in hepatitis C treatment initiation among HIV/hepatitis C virus-coinfected men engaged in primary care in a multisite community health centre in Maryland: a retrospective cohort study |
| Q36514676 | Underascertainment of acute hepatitis C virus infections in the U.S. surveillance system: a case series and chart review |